Fitch affirms Abbott Laboratories

Fitch Ratings said it affirmed Abbott Laboratories' ratings and has also assigned an AA- bank loan rating pertaining to its $3 billion uncommitted lines of credit that provides a backstop to the company's commercial paper program.

The outlook is stable.

Affirmed ratings include the senior unsecured debt at AA- and commercial paper rating at F1+.

Fitch said Abbott's rating and stable outlook reflect its well-diversified product portfolio with offerings in human pharmaceuticals, medical technology, adult and pediatric nutritionals and clinical laboratory diagnostics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.